| Schedule of earnings per share |
The following table sets forth the calculation of basic and diluted net loss per share attributable to common stockholders during the three and six months ended June 30, 2026 and 2025: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | 2026 | | 2025 | | 2026 | | 2025 | | | | | | | | | | Net loss attributable to Nuvve Holding Corp. common stockholders | $ | (7,148,587) | | | $ | (13,378,800) | | | $ | (12,982,806) | | | $ | (20,251,803) | | | Weighted-average shares used to compute net loss per share attributable to Nuvve common stockholders, basic and diluted | 494,606 | | | 8,769 | | | 348,857 | | | 5,657 | | | Net Loss per share attributable to Nuvve common stockholders, basic and diluted | $ | (14.45) | | | $ | (1,525.62) | | | $ | (37.22) | | | $ | (3,579.73) | |
|
| Schedule of antidilutive securities excluded from the computation of earnings per share |
The following outstanding shares of common stock equivalents were excluded from the calculation of the diluted net loss per share attributable to Nuvve common stockholders because their effect would have been anti-dilutive: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | 2026 | | 2025 | | 2026 | | 2025 | | Stock options issued and outstanding | 10,438 | | 9 | | | 10,438 | | 9 | | | | | | | | | | | Public warrants | — | | | 10 | | | — | | | 10 | | | | | | | | | | | | | | | | | | | PIPE warrants | — | | | 5 | | | — | | | 5 | | | | | | | | | | | | | | | | | | | 2022 July Institutional/Accredited Investor Warrants | 14 | | | 14 | | | 14 | | | 14 | | | | | | | | | | | Underwriter Warrant - February 2024 offering | 36 | | | 35 | | | 36 | | | 35 | | | 2024 February Institutional/Accredited Investor Warrants - series A | 667 | | | 667 | | | 667 | | | 667 | | | | | | | | | | | 2024 February Institutional/Accredited Investor Warrants - series C | 42 | | | 42 | | | 42 | | | 42 | | | 2024 October Institutional/Accredited Investor Warrants | 1,436 | | | 522 | | | 1,436 | | | 522 | | | 2024 December Institutional/Accredited Investor Warrants | — | | | 386 | | | — | | | 386 | | | 2025 March Institutional/Accredited Investor Warrants | — | | | 2,073 | | | — | | | 2,073 | | | 2025 April Institutional/Accredited Investor Warrants | — | | | 1,644 | | | — | | | 1,644 | | | 2025 May Institutional/Accredited Investor Warrants | 28,544 | | | 7,419 | | | 28,544 | | | 7,419 | | | | | | | | | | | 2025 July Institutional/Accredited Investor Warrants | 402 | | | — | | | 402 | | | — | | | 2025 September Institutional/Accredited Investor Warrants | 5,465 | | | — | | | 5,465 | | | — | | | 2025 November Institutional/Accredited Investor Warrants | 13,663 | | | — | | | 13,663 | | | — | | | 2025 December 17, Institutional/Accredited Investor Warrants | 5,465 | | | — | | | 5,465 | | | — | | | 2025 December 26 Institutional/Accredited Investor Warrants | 5,465 | | | — | | | 5,465 | | | — | | | 2025 December 30 Institutional/Accredited Investor Warrants | 140,825 | | | — | | | 140,825 | | | — | | | 2025 December Institutional/Accredited Investor Pre-Funded Warrants | 1,543 | | | — | | | 1,543 | | | — | | | 2026 January Institutional/Accredited Investor Warrants | 12,387 | | | — | | | 12,387 | | | — | | | 2026 February Institutional/Accredited Investor Warrants | 13,663 | | | — | | | 13,663 | | | — | | | 2026 March 6 Institutional/Accredited Investor Warrants | 16,943 | | | — | | | 16,943 | | | — | | | 2026 March 27 Institutional/Accredited Investor Warrants | 98,138 | | | — | | | 98,138 | | | — | | | 2026 April 13 Institutional/Accredited Investor Warrants | 32,598 | | | — | | | 32,598 | | | — | | | May 2025 Consulting Warrants | 12,500 | | | — | | | 12,500 | | | — | | | May 2025 Consulting Warrants | 2,778 | | | — | | | 2,778 | | | — | | | Convertible preferred stock | 273,830 | | | — | | | 273,830 | | | — | | | | | | | | | | | Total | 676,842 | | 12,826 | | 676,842 | | 12,826 | | | | | | | | |
|